Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-11-15

Clinical Trial Update: Combined Glucocorticoid Adrenergic Therapy For Wheezy Preschool Children [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating combined glucocorticoid and adrenergic therapy for wheezing in preschool children has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide/Formoterol (budesonide/formoterol)

Snippet

Sponsor: University of Calgary | Conditions: Wheeze | Phase 4 | Status: WITHDRAWN